Urolithin A Half-Life: How Long Does It Stay in Your Body?
Key takeaways
- Oral urolithin A is extensively metabolized into glucuronide and sulfate conjugates, so blood tests mostly detect these forms rather than “free” urolithin A.
- Plasma levels typically peak within a few hours of a dose and stay measurable for around a day.
- Once-daily dosing is used in most human studies because circulating conjugates persist well beyond a few hours.
- Food-derived urolithin A is unreliable because only some people’s gut bacteria convert the precursors; direct supplementation bypasses that lottery.
- With consistent daily use, blood levels build toward a steady state.
What happens to urolithin A after you take it?
“Half-life” is a pharmacology term for how long it takes your body to clear half of a substance from the bloodstream. For urolithin A the honest answer is a little more involved than a single number, because of what your body does to the molecule almost immediately after you absorb it.
Once urolithin A is absorbed from the gut, the intestinal wall and liver rapidly attach chemical tags to it — mostly glucuronic acid, and some sulfate — through a process called conjugation. The result is that very little “free” urolithin A circulates in your blood; instead, you carry mostly urolithin A glucuronide and related conjugates. This is a normal way the body handles many plant-derived compounds, and it is well documented for urolithin A in both the first-in-human work and later reviews (Andreux et al., 2019, Nature Metabolism — HUMAN; Yuan et al., 2026, Journal of Food Science — review).
| Stage | Rough timeframe | What’s happening |
|---|---|---|
| Absorption | First 1–2 hours | Urolithin A moves from the gut into the bloodstream |
| Conjugation | Within hours | Gut wall and liver convert most of it to glucuronide/sulfate forms |
| Peak in plasma | A few hours after dosing | Circulating conjugates reach their highest levels |
| Persistence | Up to about a day | Conjugated urolithin A remains measurable in blood |
| Steady state | Days of daily use | Levels accumulate and plateau with repeat dosing |
So what is the half-life, exactly?
Different studies report different numbers, which is why no single “official” half-life for urolithin A exists. The practical takeaway from human pharmacokinetic work is that circulating conjugates rise within a few hours of a dose and remain detectable for roughly a day — long enough that a single daily dose keeps a meaningful presence in the blood (D’Amico et al., 2021, review). Pharmacokinetic modeling of urolithin A has also explored how its bioavailability behaves across doses, reinforcing that the conjugated metabolites, rather than free urolithin A, dominate what circulates (Aichinger et al., 2023, Molecular Nutrition & Food Research — modeling).
Why the variation? Half-life estimates depend on the dose, whether it is taken with food, which metabolite is being measured, and individual differences in metabolism. So the most useful framing is not a precise number of hours but the shape of the curve: a few hours to peak, and a slow decline over roughly the following day.
Why your gut changes the picture for food sources
There is a second reason blood levels of urolithin A vary so much between people, and it happens before absorption. Your body does not get urolithin A directly from food — it has to be produced by gut bacteria from ellagitannin precursors in pomegranate, walnuts, and berries. Only a subset of people harbor the microbes needed to make meaningful amounts, so two people eating the same pomegranate can end up with very different urolithin A exposure.
Research on direct supplementation showed it can produce consistent urolithin A levels across a population, sidestepping the gut-conversion lottery entirely (Singh et al., 2021, European Journal of Clinical Nutrition — HUMAN). That predictability is a large part of why a standardized daily dose — such as SOMA Urolithin A gummies — is used instead of relying on diet alone.
What influences your personal urolithin A levels?
If “half-life” describes how fast a dose leaves your blood, several other factors shape how much is there in the first place and how steadily it holds. Understanding them explains why two people on the same product can have different readings.
| Factor | How it affects your levels |
|---|---|
| Gut microbiome (converter status) | Determines how much you make from food; the single largest source of person-to-person variation |
| Dose | A larger standardized dose raises peak plasma levels of the conjugates |
| Taking it with fat | Urolithin A is fat-soluble, so a meal with some fat may support absorption |
| Daily consistency | Regular dosing builds levels toward a steady state; skipped days let them dip |
| Individual metabolism | Conjugation and clearance rates differ between people, shifting the exact curve |
The practical upshot is that a standardized supplement controls two of these variables for you — it fixes the dose and removes the converter-status lottery — while the rest comes down to your own biology and how consistently you take it.
Clearance from the blood is not the same as the effect
It is easy to assume that once urolithin A clears your bloodstream in about a day, its usefulness is gone until the next dose. Pharmacokinetics and biology are not the same thing. The blood level tells you how much is circulating; it does not tell you how long the downstream cellular processes take to play out. Urolithin A is studied for supporting mitophagy and mitochondrial quality — changes that unfold over weeks of consistent exposure, which is exactly why the randomized human trials dosed it daily for roughly four months rather than measuring the effect of a single pill (Singh et al., 2022, Cell Reports Medicine — HUMAN). A short blood half-life and a slow-building biological effect can coexist, and for urolithin A they do.
What this means for how you take it
Because circulating conjugates peak within hours and taper over about a day, a once-daily dose is the pattern used in the human trials, and it is a sensible default. A few practical notes follow from the pharmacokinetics:
Consistency beats timing
The randomized human trials dosed urolithin A daily over roughly four months (Singh et al., 2022, Cell Reports Medicine — HUMAN). Taking it at the same time each day helps levels build toward and hold a steady state; the exact hour matters less than not skipping days.
With or without food
Urolithin A is fat-soluble, so taking it with a meal that contains some fat is a reasonable habit, though the trials did not hinge on a strict food rule. Pick the routine you will actually stick to.
Frequently asked questions
Does urolithin A build up in my body over time?
With daily dosing, blood levels of the conjugated metabolites rise and settle into a steady state over several days — a normal pattern for a once-daily supplement, not a sign of harmful accumulation. Human studies report it is well tolerated.
Why don’t blood tests show much “free” urolithin A?
Because your gut wall and liver conjugate most of it almost immediately. What circulates is mainly urolithin A glucuronide and sulfate, which is expected and well documented.
If it clears in about a day, why take it long-term?
Clearance from the blood is different from biological effect. The cellular processes urolithin A is studied for play out over weeks and months, which is why trials run for roughly four months rather than measuring a single dose.
Does taking more make it last longer?
Higher doses raise peak levels but do not fundamentally change the once-daily rhythm, and more is not automatically better. Follow the dose on a standardized product rather than trying to extend its presence by overdosing.
Will coffee or alcohol change how long it lasts?
There is no strong human evidence that everyday coffee or moderate alcohol meaningfully alters urolithin A pharmacokinetics. If you have specific concerns about interactions, ask your healthcare provider.
Support your cellular health, every day
SOMA delivers a high-potency 1,000 mg dose of Urolithin A in one simple daily gummy — no guesswork, no converter-status lottery.
Shop SOMA Urolithin A Gummies →These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.